StockWatch
·
Other Pharmaceuticals
Quarterly ResultMay 14, 2026, 08:37 AM

Synergy CHC Q1 Revenue $5.49M, Net Loss ($2.57M)

AI Summary

Synergy CHC Corp. reported a significant decline in its first quarter 2026 financial results, with revenue falling 32.8% to $5.49 million and a net loss of ($2.57) million, compared to net income of $0.88 million in the prior year. This was primarily due to the non-recurrence of $1.5 million in license revenue from 2025 and out-of-stock issues for its Flat Tummy brand. Despite the overall decline, the company highlighted strong growth in its functional beverage business, generating over $650,000 in revenue for the quarter and an estimated annual run rate exceeding $4 million. The company also raised approximately $2.7 million through an ATM equity offering subsequent to quarter-end.

Key Highlights

  • Revenue decreased 32.8% to $5.49 million in Q1 2026 from $8.17 million in Q1 2025.
  • Net loss was ($2.57) million in Q1 2026, compared to net income of $0.88 million in Q1 2025.
  • Diluted EPS was ($0.23) in Q1 2026, down from $0.10 in Q1 2025.
  • Functional beverage revenue exceeded $650,000 in Q1 2026, surpassing total beverage revenue for all of 2025.
  • Beverage division is operating at an estimated annual run rate exceeding $4 million.
  • Cash and cash equivalents were $0.30 million as of March 31, 2026, down from $2.6 million on December 31, 2025.
  • Working capital deficit was $0.50 million as of March 31, 2026, compared to a $1.78 million surplus previously.
  • Subsequent to quarter-end, Synergy raised approximately $2.7 million in gross proceeds via an ATM equity offering.